Epigenetic aberrations during oncogenesis

被引:127
作者
Hatziapostolou, Maria [1 ,2 ]
Iliopoulos, Dimitrios [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
Epigenetics; Networks; Methylation; Histones; MicroRNAs; Oncogenic transformation; HISTONE DEACETYLASE INHIBITORS; DEMETHYLASE JMJD3 CONTRIBUTES; CPG ISLAND HYPERMETHYLATION; PUTATIVE TUMOR-SUPPRESSOR; ACUTE MYELOID-LEUKEMIA; BINDING PROTEIN MECP2; DNA METHYLATION; CHROMOSOMAL INSTABILITY; PROMOTER METHYLATION; PROSTATE-CANCER;
D O I
10.1007/s00018-010-0624-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aberrant epigenetic landscape of a cancer cell is characterized by global genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor genes, and changes in histone modification patterns, as well as altered expression profiles of chromatin-modifying enzymes. Recent advances in the field of epigenetics have revealed that microRNAs' expression is also under epigenetic regulation and that certain microRNAs control elements of the epigenetic machinery. The reversibility of epigenetic marks catalyzed the development of epigenetic-altering drugs. However, a better understanding of the intertwined relationship between genetics, epigenetics and microRNAs is necessary in order to resolve how gene expression aberrations that contribute to tumorigenesis can be therapeutically corrected.
引用
收藏
页码:1681 / 1702
页数:22
相关论文
共 226 条
[1]   Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells [J].
Abbosh, Phillip H. ;
Montgomery, John S. ;
Starkey, Jason A. ;
Novotny, Milos ;
Zuhowski, Eleanor G. ;
Egorin, Merrill J. ;
Moseman, Annie P. ;
Golas, Adam ;
Brannon, Kate M. ;
Balch, Curtis ;
Huang, Tim H. M. ;
Nephew, Kenneth P. .
CANCER RESEARCH, 2006, 66 (11) :5582-5591
[2]   The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence [J].
Agger, Karl ;
Cloos, Paul A. C. ;
Rudkjaer, Lise ;
Williams, Kristine ;
Andersen, Gitte ;
Christensen, Jesper ;
Helin, Kristian .
GENES & DEVELOPMENT, 2009, 23 (10) :1171-1176
[3]   Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia [J].
Agirre, Xabier ;
Vilas-Zornoza, Amaia ;
Jimenez-Velasco, Antonio ;
Ignacio Martin-Subero, Jose ;
Cordeu, Lucia ;
Garate, Leire ;
San Jose-Eneriz, Edurne ;
Abizanda, Gloria ;
Rodriguez-Otero, Paula ;
Fortes, Puri ;
Rifon, Jose ;
Bandres, Eva ;
Jose Calasanz, Maria ;
Martin, Vanesa ;
Heiniger, Anabel ;
Torres, Antonio ;
Siebert, Reiner ;
Roman-Gomez, Jose ;
Prosper, Felipe .
CANCER RESEARCH, 2009, 69 (10) :4443-4453
[4]   GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer [J].
Akiyama, Y ;
Watkins, N ;
Suzuki, H ;
Jair, KW ;
van Engeland, M ;
Esteller, M ;
Sakai, H ;
Ren, CY ;
Yuasa, Y ;
Herman, JG ;
Baylin, SB .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (23) :8429-8439
[5]   PTEN promoter methylation in sporadic thyroid carcinomas [J].
Alvarez-Nuñez, F ;
Bussaglia, E ;
Mauricio, D ;
Ybarra, J ;
Vilar, M ;
Lerma, E ;
de Leiva, A ;
Matias-Guju, X .
THYROID, 2006, 16 (01) :17-23
[6]  
Andrews PGP, 2007, INT J ONCOL, V30, P357
[7]   Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation [J].
Ayyanathan, K ;
Lechner, MS ;
Bell, P ;
Maul, GG ;
Schultz, DC ;
Yamada, Y ;
Tanaka, K ;
Torigoe, K ;
Rauscher, FJ .
GENES & DEVELOPMENT, 2003, 17 (15) :1855-1869
[8]   Epigenetic Silencing of miR-137 Is an Early Event in Colorectal Carcinogenesis [J].
Balaguer, Francesc ;
Link, Alexander ;
Lozano, Juan Jose ;
Cuatrecasas, Miriam ;
Nagasaka, Takeshi ;
Boland, C. Richard ;
Goel, Ajay .
CANCER RESEARCH, 2010, 70 (16) :6609-6618
[9]   Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS [J].
Barradas, Marta ;
Anderton, Emma ;
Acosta, Juan Carlos ;
Li, SiDe ;
Banito, Ana ;
Rodriguez-Niedenfuehr, Marc ;
Maertens, Goedele ;
Banck, Michaela ;
Zhou, Ming-Ming ;
Walsh, Martin J. ;
Peters, Gordon ;
Gil, Jesus .
GENES & DEVELOPMENT, 2009, 23 (10) :1177-1182
[10]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29